Effects of hepatitis C virus infection on menopause status and symptoms

Menopause

Volumn 16, Issue 2, 2009, Pages 401-406

  Cieloszyk, Kinga ^a   Hartel, Diana ^b   Moskaleva, Galina ^b   Schoenbaum, Ellie E ^a,b  

^a Division of Infectious Diseases   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Depression; Hepatitis C virus; Liver fibrosis; Menopause; Vasomotor symptoms

Indexed keywords

VIRUS ANTIBODY; VIRUS RNA;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DRUG USE; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; MAJOR CLINICAL STUDY; MENOPAUSAL SYNDROME; MENOPAUSE; NULLIPARA; ONSET AGE; PHYSICAL ACTIVITY; PREMENOPAUSE; PREVALENCE; VASOMOTOR DISORDER;

ADULT; CASE-CONTROL STUDIES; FEMALE; HEPATITIS C; HOT FLASHES; HUMANS; MENOPAUSE; MIDDLE AGED;

EID: 67649316368     PISSN: 10723714     EISSN: None     Source Type: Journal    
DOI: 10.1097/gme.0b013e318186d7cf     Document Type: Article

References (39)

1. Brambilla DJ, McKinlay SM, Johannes CB. Defining the perimenopause for application in epidemiologic investigations. Am J Epidemiol 1994;140:1091-1095.
2. World Health Organization. Research on the Menopause in the 1990s: Report of a WHO Scientific Working Group. Geneva, Switzerland: WHO, 1996. WHO Technical Report Series No. 866.
3. Mitchell ES, Woods NF. Symptom experiences of midlife women: observations from the Seattle Midlife Women's Health Study. Maturitas 1996;25:1-10.
4. Wilbur J, Miller AM, Montgomery A, Chandler P. Sociodemographic characteristics, biological factors, and symptom reporting in midlife women. Menopause 1998;5:43-51.
5. Schoenbaum EE, Hartel D, Lo Y, et al. HIV infection, drug use, and onset of natural menopause. Clin Infect Dis 2005;41:1517-1524.
6. Gold EB, Bromberg J, Crowford S, et al. Factors associated with age at natural menopause in a multiethnic sample of midlife women. Am J Epidemiol 2001;153:865-874.
7. Miller SA, Santoro N, Lo Y, et al. Menopause symptoms in HIV-infected and drug-using women. Menopause 2005;12:348-356.
8. Gold E, Sternfeld B, Kelsey JL, et al. Relation of demographic and lifestyle factors to symptoms in a multi-racial/ethic population of women 45-55. Am J Epidemiol 2000;152:463-473.
9. Hunter M, Battersby R, Whitehead M. Relationship between psychological symptoms, somatic complaints and menopausal status. Maturitas 1986;8:217-228.
10. Cooper GS, Sandler DP, Bohlig M. Active and passive smoking and the occurrence of natural menopause. Epidemiology 1999;10:771-773.
11. Bromberger JT, Matthews KA, Kuller LH, Wing RR, Meilahn EN, Plantinga P. Prospective study of the determinants of age at menopause. Am J Epidemiol 1997;145:124-133.
12. Torgerson DJ, Avenell A, Russell IT, Reid DM. Factors associated with onset of menopause in women aged 45-49. Maturitas 1994;19:83-92.
13. Dorman JS, Steenkiste AR, Foley TP, et al. Menopause in type 1 diabetic women: is it premature? Diabetes 2001;50:1857-1862.
14. Weisinger JR, Bellorin-Font E. Postmenopausal osteoporosis in the dialysis patient. Curr Opin Nephrol Hypertens 2003;12:381-386.
15. Jabiry-Zienjewicz Z, Kaminski P, Bobrowska K, et al. Menstrual cycle and sex hormones in perimenopausal women after liver transplantation. Transplant Proc 2006;38:2909-2912.
16. Valimaki M, Pelkonen R, Salaspuro M, Harkonen M, Hirvonen E, Ylikahri R. Sex hormones in amenorrheic women with alcoholic liver disease. J Clin Endocrinol Metab 1984;59:133-138.
17. Armstrong GL, Wasley A, Simard EP, McQuillan GM, Kuhnert WL, Alter MJ. The prevalence of hepatitis C virus infection in the United States, 1999 through 2002. Ann Intern Med 2006; 144:705-714.
18. Thomas DL, Vlahov D, Solomon L, et al. Correlates of hepatitis C virus infections among injection drug users. Medicine (Baltimore) 1995; 74:212-220.
19. DiMartino V, Lebray P, Myers RP, et al. Progression of liver fibrosis in women infected with hepatitis C: long-term benefits of estrogen exposure. Hepatology 2004;40:1426-1433.
20. Yu M, Chang H, Chang S, et al. Role of reproductive factors in hepatocellular carcinoma: impact of hepatitis BY and CYrelated risk. Hepatology 2003;38:1393-1400.
21. Shimizu I. Impact of oestrogens on the progression of liver disease. Liver Int 2003;23:63-69.
22. Burkman RT, Collins JA, Green RA. Current perspectives on benefits and risks of hormone replacement therapy. Am J Obstet Gynecol 2001; 185:S13-S23.
23. Dennerstein L, Dudley EC, Hopper JL, Guthrie JR, Burger HG. A prospective population-based study of menopausal symptoms. Obstet Gynecol 2000;96:351-358.
24. Freeman EW, Grisso JA, Berlin J, Sammel M, Garcia-Espana B, Hollander L. Symptom reports from a cohort of African American and white women in the late reproductive years. Menopause 2000;8:33-42.
25. Lang CA, Conrad S, Garrett L, et al. Symptom prevalence and clustering of symptoms in people living with chronic hepatitis C infections. J Pain Symptom Manage 2006;31:335-344.
26. Leri F, Bruneau J, Stewart J. Understanding polydrug use: review of heroin and cocaine co-use. Addiction 2003;98:7-22.
27. Radloff LS. The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas 1977;1:385-401.
28. Hosmer DW, Lemeshow S. Applied Logistic Regression. New York, NY: Wiley, 1989.
29. Cejtin HE, Kim S, Taylor RN, et al. Menopause in women in the Women's Interagency HIV Study (WIHS). In: Program and Abstracts of the XV International AIDS Conference; July 11-16, 2004; Bangkok, Thailand. Abstract WePeD6504.
30. Avis NE, McKinlay SM. The Massachusetts Women's Health Study: an epidemiologic investigation of the menopause. J Am Med Womens Assoc 1995;50:45-49.
31. Grisso JA, Freeman EW, Maurin E, Garcia-Espana B, Berlin JA. Racial differences in menopause information and the experience of hot flashes. J Gen Intern Med 1999;14:98-103.
32. Riolo SA, Nguyen TA, Greden JF, King CA. Prevalence of depression by race/ethnicity: findings from the National Health and Nutrition Examination Survey III. Am J Public Health 2005;95:998-1000.
33. Gallegos-Orozco JF, Fuentes AP, Argueta JG, et al. Health-related quality of life and depression in patients with chronic hepatitis C. Arch Med Res 2003;34:124-129.
34. Thompson SC, Nanni C, Levine A. The stressors and stress of being HIV-positive. AIDS Care 1996;8:5-14.
35. Younossi Z, Kallman J, Kincaid J. The effects of HCV infection and management on health-related quality of life. Hepatology 2007;45: 806-816.
36. Schwingl PJ, Hulka BS, Harlow SD. Risk factors for menopausal hot flashes. Obstet Gynecol 1994;84:29-34.
37. Anand BS, Velez M. Assessment of correlation between serum titers of hepatitis C virus and severity of liver disease. World J Gastroenterol 2004;10:2409-2411.
38. Pelosi MA, Sama JC, Caterini H, et al. Galactorrhea-amenorrhea syndrome associated with heroin addiction. Am J Obstet Gynecol 1974; 118:966-970.
39. Bai J, Greenwald E, Caterini H, Kaminetzky HA. Drug-related menstrual aberrations. Obstet Gynecol 1974;44:713-719.